Recombinant Human S100A13 Protein，His

S100A13 is a member of the S100 protein family, known for being calcium-binding proteins that play critical roles in various cellular processes, including cell differentiation, proliferation, and apoptosis. Recent studies have highlighted its involvement in cancer progression, particularly in tumor growth, metastasis, and the modulation of inflammatory responses. The overexpression of S100A13 has been linked to poor prognosis in several malignancies, making it a potential biomarker for cancer diagnosis and a target for therapeutic interventions. Moreover, S100A13 has been shown to interact with other signaling pathways, such as those involving the RAGE receptor, further complicating its role in cellular signaling. Given its diverse functions and implications in both normal physiology and pathological conditions, researchers are increasingly focusing on recombinant S100A13 protein for functional studies. This includes examining its structure-function relationship, investigating its interactions with other proteins, and exploring its potential as a therapeutic target or diagnostic marker in various diseases. The production of recombinant S100A13 allows for in-depth analysis of its biological activities and the development of potential inhibitors or modulators that could alter its function in disease contexts. As understanding the molecular mechanisms underlying S100A13's role in diseases progresses, it holds promise for advancing therapeutic strategies aimed at targeting S100A13-related pathways in oncology and beyond.